
ASM Microbe 2019: Day 1 Update
Today was the first day of the annual ASM Microbe Conference and we’re excited to be attending! You can find a daily video update, our pick of the posters, the biggest news stories and more in our daily updates.
Today was the first day of the annual ASM Microbe Conference and we’re excited to be attending! You can find a daily video update, our pick of the posters, the biggest news stories and more in our daily updates.
New research investigating possible interactions between Epstein–Barr virus and neurological diseases has successfully infected neuronal-like cells in vitro, with the hope to use these as a model for studying this virus in the future.
Individuals with schizophrenia also have higher level of antibodies against the Epstein-Barr virus, according to new research.
Michael Pender discusses promising interim findings from a Phase 1 study investigating a novel treatment for multiple sclerosis based on the realtionship with Epstein–Barr virus.
Researchers have suggested that a virion protein known as BNRF1, produced by the Epstein–Barr Virus, may be responsible for tumor formation.